We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-14.64%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$683B
AUM Growth
-$118B
Cap. Flow
+$16.8B
Cap. Flow %
2.46%
Top 10 Hldgs %
22.55%
Holding
5,106
New
131
Increased
2,878
Reduced
1,465
Closed
89

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$956M
2
AAPL icon
Apple
AAPL
+$935M
3
WBD icon
Warner Bros
WBD
+$783M
4
HD icon
Home Depot
HD
+$626M
5
AMZN icon
Amazon
AMZN
+$476M

Sector Composition

Rank Sector Weight
1 Technology 23.95%
2 Healthcare 14.76%
3 Financials 13.17%
4 Consumer Discretionary 10.3%
5 Industrials 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
3551
Immunic
IMUX
$225M
$745K ﹤0.01%
21,498
-14,598
-40% -$935K
FOA icon
3552
Finance of America Companies
FOA
$206M
$744K ﹤0.01%
47,444
+16,663
+54% +$385K
LFT
3553
Lument Finance Trust
LFT
$36.4M
$743K ﹤0.01%
312,200
+2,584
+0.8% +$6.66K
CUE icon
3554
Cue Biopharma
CUE
$133M
$742K ﹤0.01%
9,936
-8,344
-46% -$976K
ENZ
3555
DELISTED
Enzo Biochem, Inc.
ENZ
$738K ﹤0.01%
356,567
+6,746
+2% +$16.7K
BLU
3556
DELISTED
BELLUS Health Inc.
BLU
$738K ﹤0.01%
80,113
+23,295
+41% +$191K
PLM
3557
DELISTED
PolyMet Mining Corp.
PLM
$738K ﹤0.01%
268,646
+9,244
+4% +$28.5K
STRR
3558
Star Equity Holdings
STRR
$37.8M
$736K ﹤0.01%
23,443
+5,952
+34% +$211K
RJET
3559
Republic Airways Holdings
RJET
$962M
$732K ﹤0.01%
22,306
-14,910
-40% -$701K
TRVN
3560
DELISTED
Trevena, Inc.
TRVN
$732K ﹤0.01%
2,830
-2,382
-46% -$524K
EVLO
3561
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$731K ﹤0.01%
17,336
-9,960
-36% -$462K
TXMD icon
3562
TherapeuticsMD
TXMD
$24.1M
$729K ﹤0.01%
73,283
-59,278
-45% -$566K
FORA
3563
DELISTED
Forian
FORA
$727K ﹤0.01%
165,665
-145,272
-47% -$559K
PHX
3564
DELISTED
PHX Minerals
PHX
$723K ﹤0.01%
238,097
-30,344
-11% -$106K
WATT icon
3565
Energous
WATT
$83.2M
$723K ﹤0.01%
1,207
+41
+4% +$25K
MIMO
3566
DELISTED
Airspan Networks Holdings Inc
MIMO
$720K ﹤0.01%
240,920
+2,066
+0.9% +$5.77K
CAPR icon
3567
Capricor Therapeutics
CAPR
$252M
$719K ﹤0.01%
206,063
-15,549
-7% -$55.2K
ERO icon
3568
Ero Copper
ERO
$3.57B
$719K ﹤0.01%
74,548
+17,725
+31% +$221K
AIRG icon
3569
Airgain
AIRG
$68.5M
$714K ﹤0.01%
88,042
-3,059
-3% -$27.6K
PAVM icon
3570
PAVmed
PAVM
$32.9M
$714K ﹤0.01%
1,698
-1,089
-39% -$526K
PRLD icon
3571
Prelude Therapeutics
PRLD
$432M
$708K ﹤0.01%
135,641
-71,935
-35% -$366K
TAST
3572
DELISTED
Carrols Restaurant Group, Inc.
TAST
$704K ﹤0.01%
348,907
-271,977
-44% -$508K
CNVS icon
3573
Cineverse
CNVS
$70.4M
$703K ﹤0.01%
71,453
+4,896
+7% +$66K
CYPH
3574
Cypherpunk Technologies Inc
CYPH
$68.9M
$700K ﹤0.01%
60,877
STIM icon
3575
Neuronetics
STIM
$217M
$696K ﹤0.01%
216,839
-176,427
-45% -$512K

Similar funds

Geode Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 131 new positions and exited 89, leaving the 5,106-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
  • Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
  • Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
  • Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
  • Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
  • Geode Capital Management opened 131 new positions and closed 89 in Q2 2022.
  • Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.

Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.